Credit Suisse’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.2M | Buy |
68,119
+12,063
| +22% | +$390K | ﹤0.01% | 1779 |
|
|
2023
Q4 | $2.36M | Buy |
56,056
+24
| +0% | +$1.01K | ﹤0.01% | 1779 |
|
|
2023
Q3 | $2.15M | Sell |
56,032
-6,562
| -10% | -$252K | ﹤0.01% | 1789 |
|
|
2023
Q2 | $1.19M | Buy |
62,594
+12,192
| +24% | +$231K | ﹤0.01% | 2258 |
|
|
2023
Q1 | $782K | Buy |
50,402
+1,491
| +3% | +$23.1K | ﹤0.01% | 2454 |
|
|
2022
Q4 | $868K | Buy |
48,911
+8,632
| +21% | +$153K | ﹤0.01% | 2425 |
|
|
2022
Q3 | $225K | Buy |
40,279
+3,266
| +9% | +$18.2K | ﹤0.01% | 3186 |
|
|
2022
Q2 | $145K | Buy |
37,013
+2,140
| +6% | +$8.38K | ﹤0.01% | 3417 |
|
|
2022
Q1 | $192K | Buy |
34,873
+11,413
| +49% | +$62.8K | ﹤0.01% | 3367 |
|
|
2021
Q4 | $200K | Buy |
23,460
+2,020
| +9% | +$17.2K | ﹤0.01% | 3443 |
|
|
2021
Q3 | $186K | Sell |
21,440
-47,139
| -69% | -$409K | ﹤0.01% | 3394 |
|
|
2021
Q2 | $724K | Buy |
68,579
+20,267
| +42% | +$214K | ﹤0.01% | 2820 |
|
|
2021
Q1 | $775K | Sell |
48,312
-17,292
| -26% | -$277K | ﹤0.01% | 2708 |
|
|
2020
Q4 | $3.03M | Buy |
65,604
+26,518
| +68% | +$1.22M | ﹤0.01% | 1868 |
|
|
2020
Q3 | $1.38M | Buy |
39,086
+25,708
| +192% | +$905K | ﹤0.01% | 2066 |
|
|
2020
Q2 | $325K | Buy |
+13,378
| New | +$325K | ﹤0.01% | 2908 |
|